Amgen Inc
(AMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,352,000 | 3,687,000 | 3,805,000 | 8,281,000 | 5,806,000 |
| Marketable Securities | 21,836,000 | 16,115,000 | 15,596,000 | 14,277,000 | 16,212,000 |
| Receivables | 2,697,000 | 2,514,000 | 2,697,000 | 3,230,000 | 2,674,000 |
| Inventories | 2,954,000 | 2,966,000 | 3,019,000 | 2,838,000 | 2,773,000 |
| Other current assets | 2,489,000 | 3,020,000 | 2,250,000 | 2,049,000 | 2,208,000 |
| TOTAL | $34,328,000 | $28,302,000 | $27,367,000 | $30,675,000 | $29,673,000 |
| Non-Current Assets | |||||
| PPE Net | 5,371,000 | 5,365,000 | 5,349,000 | 5,283,000 | 5,293,000 |
| Investments And Advances | 0 | 3,414,000 | 3,412,000 | 3,411,000 | 0 |
| Intangibles | 28,343,000 | 28,398,000 | 28,230,000 | 16,254,000 | 16,354,000 |
| Other Non-Current Assets | 1,492,000 | 1,525,000 | 1,767,000 | 1,450,000 | 1,290,000 |
| TOTAL | $35,206,000 | $38,702,000 | $38,758,000 | $26,398,000 | $22,937,000 |
| Total Assets | $69,534,000 | $67,004,000 | $66,125,000 | $57,073,000 | $52,610,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,500,000 | 2,505,000 | 2,505,000 | 11,000 | 7,000 |
| Accounts payable and accrued liabilities | 982,000 | 949,000 | 787,000 | 895,000 | 1,006,000 |
| Accrued Expenses | 4,384,000 | 4,749,000 | 4,655,000 | 3,937,000 | 3,771,000 |
| TOTAL | $7,866,000 | $8,203,000 | $7,947,000 | $4,843,000 | $4,784,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,828,000 | 29,519,000 | 29,623,000 | 27,178,000 | 23,908,000 |
| Other Non-Current Liabilities | 6,458,000 | 6,541,000 | 2,961,000 | 3,324,000 | 3,324,000 |
| TOTAL | $37,286,000 | $36,060,000 | $36,082,000 | $30,502,000 | $27,232,000 |
| Total Liabilities | $45,152,000 | $44,263,000 | $44,029,000 | $35,345,000 | $32,016,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 759,607 | 757,022 | 755,007 | 754,126 | 753,356 |
| Common Shares | 29,981,000 | 29,890,000 | 29,891,000 | 29,665,000 | 29,519,000 |
| Retained earnings | -5,476,000 | -7,023,000 | -7,634,000 | -7,840,000 | -8,854,000 |
| Other shareholders' equity | -123,000 | -126,000 | -161,000 | -97,000 | -71,000 |
| TOTAL | $24,382,000 | $22,741,000 | $22,096,000 | $21,728,000 | $20,594,000 |
| Total Liabilities And Equity | $69,534,000 | $67,004,000 | $66,125,000 | $57,073,000 | $52,610,000 |